Phosphoinositide 3 Kinase, p85 alpha (PI3K p85a) (C-Term) Peptide
Quick Overview for Phosphoinositide 3 Kinase, p85 alpha (PI3K p85a) (C-Term) Peptide (ABIN5672612)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- QKGVRQKKLN EWLGNENTED QYSLVEDDED LPHHDEKTWN VGSSNRNKAE
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- PIK3R1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PIK3R1 (PI3K p85a) (Phosphoinositide 3 Kinase, p85 alpha (PI3K p85a))
-
Background
-
Phosphatidylinositol 3-kinase phosphorylates the inositol ring of phosphatidylinositol at the 3-prime position. The enzyme comprises a 110 kD catalytic subunit and a regulatory subunit of either 85, 55, or 50 kD. This gene encodes the 85 kD regulatory subunit. Phosphatidylinositol 3-kinase plays an important role in the metabolic actions of insulin, and a mutation in this gene has been associated with insulin resistance. Alternative splicing of this gene results in four transcript variants encoding different isoforms.
Alias Symbols: p85, AGM7, GRB1, IMD36, p85-ALPHA
Protein Size: 361 -
Gene ID
- 5295
-
NCBI Accession
- NM_001242466, NP_001229395
Target
-